Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
As at 2022-12-31 |
As at 2021-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification |
TELES Aktiengesellschaft
|
— | — |
| Domicile of entity |
Deutschland
|
— | — |
| Legal form of entity |
AG
|
— | — |
| Country of incorporation |
Deutschland
|
— | — |
| Address of entity's registered office |
Ordensmeisterstr. 15-16, 12099 Berlin
|
— | — |
| Description of nature of entity's operations and principal activities |
in den Geschäftsbereichen Pharma
|
— | — |
| Statement of IFRS compliance [text block] |
|
— | — |
| Disclosure of uncertainties of entity's ability to continue as going concern [text block] |
|
— | — |
| Disclosure of reclassifications or changes in presentation [text block] |
|
— | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories | — |
5,183
EUR
|
5,000
EUR
|
| Explanation of sources of estimation uncertainty with significant risk of causing material adjustment |
|
— | — |
| Disclosure of assets and liabilities with significant risk of material adjustment [text block] |
|
— | — |
| Disclosure of objectives, policies and processes for managing capital [text block] |
|
— | — |